Burke & Herbert Bank & Trust’s Eli Lilly LLY Stock Holding History

Burke & Herbert Bank & Trust’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.27M	Buy	5,231 +8	+0.2%	+$8.17K	1.56%	12
2026 Q1	$4.8M	Buy	5,223 +15	+0.3%	+$15.2K	1.33%	15
2025 Q4	$5.6M	Sell	5,208 -3,149	-38%	-$3.01M	1.55%	11
2025 Q3	$6.38M	Sell	8,357 -400	-5%	-$298K	1.37%	14
2025 Q2	$6.83M	Sell	8,757 -10	-0.1%	-$7.77K	1.53%	14
2025 Q1	$7.24M	Sell	8,767 -810	-8%	-$674K	1.74%	12
2024 Q4	$7.39M	Sell	9,577 -100	-1%	-$82.8K	1.75%	12
2024 Q3	$8.57M	Sell	9,677 -812	-8%	-$730K	1.99%	9
2024 Q2	$9.5M	Buy	10,489 +10,129	+2,814%	+$8.1M	2.31%	5
2024 Q1	$280K	Hold	360	–	–	0.21%	103
2023 Q4	$210K	Buy	+360	New	+$210K	0.15%	121
2021 Q1	–	Sell	-2,490	Closed	-$420K	–	144
2020 Q4	$420K	Hold	2,490	–	–	0.3%	97
2020 Q3	$369K	Hold	2,490	–	–	0.29%	93
2020 Q2	$409K	Hold	2,490	–	–	0.36%	78
2020 Q1	$345K	Hold	2,490	–	–	0.35%	81
2019 Q4	$327K	Buy	+2,490	New	+$289K	0.25%	102

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Burke & Herbert Bank & Trust's LLY Position: Q2 2026 in Review

Burke & Herbert Bank & Trust increased its Eli Lilly (LLY) stake by 0.15% in Q2 2026, buying an estimated $8.17K and bringing the position to 5,231 shares worth $6.27M. The position accounts for 1.56% of the portfolio, ranked #12.

Burke & Herbert Bank & Trust first reported a position in LLY in Q4 2019 and has held it in 16 quarters since. The position peaked at $9.5M in Q2 2024. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Burke & Herbert Bank & Trust held 5,231 shares of Eli Lilly worth $6.27M as of Q2 2026.
Burke & Herbert Bank & Trust bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
Eli Lilly made up 1.56% of Burke & Herbert Bank & Trust's portfolio in Q2 2026, its #12 holding.
Burke & Herbert Bank & Trust first reported a position in Eli Lilly in Q4 2019 and has held it in 16 quarters since.
Burke & Herbert Bank & Trust's Eli Lilly position peaked at $9.5M in Q2 2024.
4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Burke & Herbert Bank & Trust's 13F filing for Q2 2026, filed 7 Aug 2026.